Congenital Heart Disease GEnetic NEtwork Study (CHD GENES)
Launched by CHILDREN'S HOSPITAL MEDICAL CENTER, CINCINNATI · Sep 3, 2010
Trial Information
Current as of July 24, 2025
Recruiting
Keywords
ClinConnect Summary
The Congenital Heart Disease GEnetic NEtwork Study (CHD GENES) is a research study focused on understanding the genetic causes of congenital heart defects (CHD), which are heart problems present at birth and affect about 8 out of every 1,000 babies. This study aims to collect DNA and health information from participants to better understand how genes may influence the severity and outcomes of these heart defects. By doing this, researchers hope to find common genetic factors that contribute to CHD and how they may impact patients' health.
Anyone interested in joining the study needs to provide a signed consent form. However, some individuals won't qualify, such as those with specific minor heart conditions like isolated patent foramen ovale or certain types of heart issues related to premature birth. Participants will have their genetic material collected and will be asked questions about their health, which will help researchers gather detailed information to make important discoveries about congenital heart disease. This is an exciting opportunity to contribute to research that could lead to better treatments and outcomes for future patients.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • • Signed consent form
- Exclusion Criteria:
- • Isolated patent foramen ovale
- • Isolated prematurity-associated patent ductus arteriosus
About Children's Hospital Medical Center, Cincinnati
Children's Hospital Medical Center in Cincinnati is a leading pediatric healthcare institution dedicated to advancing child health through innovative clinical research and comprehensive patient care. Renowned for its commitment to excellence, the center conducts a wide range of clinical trials aimed at developing and evaluating new treatments and therapies for pediatric populations. With a focus on multidisciplinary collaboration and ethical research practices, Children's Hospital Medical Center strives to improve health outcomes for children while contributing to the broader scientific understanding of pediatric medicine.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
New Haven, Connecticut, United States
New York, New York, United States
New York, New York, United States
Boston, Massachusetts, United States
Boston, Massachusetts, United States
Los Angeles, California, United States
Rochester, New York, United States
Palo Alto, California, United States
Philadelphia, Pennsylvania, United States
Salt Lake City, Utah, United States
Salt Lake City, Utah, United States
San Francisco, California, United States
London, England, United Kingdom
New Haven, Connecticut, United States
New Hyde Park, New York, United States
Patients applied
Trial Officials
Amy Roberts, MD
Principal Investigator
Childrens Hospital Boston
Christine Seidman, MD
Principal Investigator
Harvard Medical School, Boston MA
Bruce Gelb, MD
Principal Investigator
Mt Sinai School of Medicine, New York NY
Martina Brueckner, MD
Principal Investigator
Yale University
Martin Tristani-Firouzi, MD
Principal Investigator
University of Utah
Wendy Chung, MD, PhD
Principal Investigator
Columbia University Medical Center, New York NY
Jon Cleveland
Principal Investigator
Children's Los Angeles
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials